Brief: Gain Therapeutics Appoints C. Evan Ballantyne As Chief Financial Officer
12/04/2023 21:33
April 12 (Reuters) - Agenus Inc AGEN.O :
* GAIN THERAPEUTICS APPOINTS C. EVAN BALLANTYNE AS CHIEF
FINANCIAL
OFFICER
* GAIN THERAPEUTICS INC - BALLANTYNE SUCCEEDS SALVATORE
CALABRESE,
EXPECTED TO REMAIN EMPLOYED FOR A REASONABLE TRANSITION PERIOD
Source text for Eikon: ID:nGNX4N30RX
Further company coverage: AGEN.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Gain Therapeutics
See all newsU.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Gain Therapeutics climbs on narrower-than-expected quarterly loss
Gain Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Gain Therapeutics Q2 net loss per share narrows as R&D expenses fall